162 related articles for article (PubMed ID: 7599043)
1. Castration plus oestrogen treatment induces but castration alone suppresses epithelial cell apoptosis in an androgen-sensitive rat prostatic adenocarcinoma.
Westin P; Brändström A; Damber JE; Bergh A
Br J Cancer; 1995 Jul; 72(1):140-5. PubMed ID: 7599043
[TBL] [Abstract][Full Text] [Related]
2. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
Brändström A; Westin P; Bergh A; Cajander S; Damber JE
Cancer Res; 1994 Jul; 54(13):3594-601. PubMed ID: 8012987
[TBL] [Abstract][Full Text] [Related]
3. Dose/response study of the effects of oestrogens on tumour growth and morphology in the Dunning R3327 prostatic adenocarcinoma.
Landström M; Damber JE; Bergh A; Tomic R
J Cancer Res Clin Oncol; 1992; 118(1):30-4. PubMed ID: 1729258
[TBL] [Abstract][Full Text] [Related]
4. Prostatic tumor regrowth after initially successful castration therapy may be related to a decreased apoptotic cell death rate.
Landström M; Damber JE; Bergh A
Cancer Res; 1994 Aug; 54(16):4281-4. PubMed ID: 7913874
[TBL] [Abstract][Full Text] [Related]
5. Castration rapidly results in a major reduction in epithelial cell numbers in the rat prostate, but not in the highly differentiated Dunning R3327 prostatic adenocarcinoma.
Westin P; Bergh A; Damber JE
Prostate; 1993; 22(1):65-74. PubMed ID: 8426839
[TBL] [Abstract][Full Text] [Related]
6. Estrogen treatment postpones the castration-induced dedifferentiation of Dunning R3327-PAP prostatic adenocarcinoma.
Landström M; Damber JE; Bergh A
Prostate; 1994 Jul; 25(1):10-8. PubMed ID: 8022707
[TBL] [Abstract][Full Text] [Related]
7. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
George DJ; Dionne CA; Jani J; Angeles T; Murakata C; Lamb J; Isaacs JT
Cancer Res; 1999 May; 59(10):2395-401. PubMed ID: 10344749
[TBL] [Abstract][Full Text] [Related]
8. Estrogen induces apoptosis in a rat prostatic adenocarcinoma: association with an increased expression of TGF-beta 1 and its type-I and type-II receptors.
Landström M; Eklöv S; Colosetti P; Nilsson S; Damber JE; Bergh A; Funa K
Int J Cancer; 1996 Aug; 67(4):573-9. PubMed ID: 8759618
[TBL] [Abstract][Full Text] [Related]
9. A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.
Johansson A; Jones J; Pietras K; Kilter S; Skytt A; Rudolfsson SH; Bergh A
Prostate; 2007 Nov; 67(15):1664-76. PubMed ID: 17854058
[TBL] [Abstract][Full Text] [Related]
10. The effect of castration on tumor growth rate and cell kinetics in hormone sensitive and hormone insensitive rat prostatic adenocarcinomas.
Salling LN; Høyer M; Overgaard J
Scand J Urol Nephrol Suppl; 1995; 172():73-9. PubMed ID: 8578260
[TBL] [Abstract][Full Text] [Related]
11. After radiotherapy testosterone stimulation is unable to increase growth in the dunning R3327-PAP prostate tumour.
Granfors T; Tomic R; Bergh A; Rydh M; Löfroth PO; Widmark A
Urol Res; 1999 Oct; 27(5):357-61. PubMed ID: 10550524
[TBL] [Abstract][Full Text] [Related]
12. Alterations of tumour cells, stroma and apoptosis in rat prostatic adenocarcinoma following treatment with histamine, interleukin-2 and irradiation.
Johansson S; Landström M; Henriksson R
Anticancer Res; 1999; 19(3A):1961-9. PubMed ID: 10470141
[TBL] [Abstract][Full Text] [Related]
13. Estrogen treatment combined with castration inhibits tumor growth more effectively than castration alone in the Dunning R3327 rat prostatic adenocarcinoma.
Landström M; Bergh A; Tomic R; Damber JE
Prostate; 1990; 17(1):57-68. PubMed ID: 1696714
[TBL] [Abstract][Full Text] [Related]
14. Supraadditive apoptotic response of R3327-G rat prostate tumors to androgen ablation and radiation.
Joon DL; Hasegawa M; Sikes C; Khoo VS; Terry NH; Zagars GK; Meistrich ML; Pollack A
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):1071-7. PubMed ID: 9276374
[TBL] [Abstract][Full Text] [Related]
15. Effect of zindoxifene on experimental prostatic tumours of the rat.
Schneider MR; Schiller CD; Humm A; von Angerer E
J Cancer Res Clin Oncol; 1991; 117(1):33-6. PubMed ID: 1997466
[TBL] [Abstract][Full Text] [Related]
16. Targeting castration-induced tumour hypoxia enhances the acute effects of castration therapy in a rat prostate cancer model.
Johansson A; Rudolfsson SH; Kilter S; Bergh A
BJU Int; 2011 Jun; 107(11):1818-24. PubMed ID: 20860653
[TBL] [Abstract][Full Text] [Related]
17. Androgen ablation leads to an upregulation and intranuclear accumulation of deoxyribonuclease I in rat prostate epithelial cells paralleling their apoptotic elimination.
Rauch F; Polzar B; Stephan H; Zanotti S; Paddenberg R; Mannherz HG
J Cell Biol; 1997 May; 137(4):909-23. PubMed ID: 9151693
[TBL] [Abstract][Full Text] [Related]
18. Antiestrogens do not counteract the inhibitory effect of estradiol-17 beta on the growth of the Dunning R3327 prostatic adenocarcinoma.
Landström M; Damber JE; Bergh A; Tomic R; Carlsson-Bostedt L; Stigbrand T
Prostate; 1988; 12(4):287-98. PubMed ID: 3393491
[TBL] [Abstract][Full Text] [Related]
19. On the effects of oestrogen in the male. Some effects of different oestrogenic substances in rats and men with prostatic carcinoma.
Daehlin L
Scand J Urol Nephrol Suppl; 1985; 91():1-44. PubMed ID: 3868029
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
Shiota M; Itsumi M; Takeuchi A; Imada K; Yokomizo A; Kuruma H; Inokuchi J; Tatsugami K; Uchiumi T; Oda Y; Naito S
Endocr Relat Cancer; 2015 Dec; 22(6):889-900. PubMed ID: 26311513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
